What Is Lung Damage from Vaping
Lung damage from vaping refers to injuries and diseases caused by inhaling aerosolized chemicals in e-cigarettes and similar devices. The aerosol can contain nicotine, ultrafine particles, volatile organic compounds, and heavy metals such as lead and nickel. Public health agencies have documented acute lung injury and chronic respiratory conditions linked to these exposures. The U.S. Food and Drug Administration (FDA) has received reports of severe lung illnesses tied to vaping products, especially those containing tetrahydrocannabinol (THC) or vitamin E acetate. For background on vaping products and regulatory oversight, see the FDA's e-cigarette page at FDA Health Effects of E-Cigarettes.
In 2019, the Centers for Disease Control and Prevention (CDC) identified a national outbreak of e-cigarette or vaping product use-associated lung injury (EVALI). The outbreak was strongly associated with vitamin E acetate in THC-containing vaping products. By early 2020, the CDC had recorded thousands of hospitalized cases and dozens of deaths. The agency later reported that most patients had used THC-containing products from informal sources. The CDC continues to monitor vaping-related lung injuries and updates its guidance as new data emerge. Detailed CDC resources on EVALI are available at CDC Severe Lung Disease and E-Cigarettes.
Key Health Risks and Clinical Findings
Clinicians have observed a range of lung injuries from vaping, including lipid pneumonia, acute respiratory distress syndrome, and bronchiolitis obliterans. Lipid pneumonia can occur when inhaled oils, such as vitamin E acetate, accumulate in the lungs. Acute respiratory distress syndrome is a severe, life-threatening condition that requires intensive care. Bronchiolitis obliterans, sometimes called popcorn lung, involves scarring of the small airways and can cause permanent breathing problems. These conditions have been reported in both nicotine and THC users, though the chemical composition of the inhaled aerosol plays a key role in the type and severity of injury.
Long-Term and Chronic Effects
Long-term vaping can lead to chronic bronchitis-like symptoms, reduced lung function, and increased susceptibility to respiratory infections. Studies have shown that e-cigarette aerosol can impair immune responses in the lungs and promote inflammation. Some research suggests that repeated exposure may increase the risk of developing chronic obstructive pulmonary disease (COPD) over time. The American Lung Association has warned that vaping can cause irreversible lung damage and exacerbate existing respiratory conditions. The American Lung Association's vaping overview is available at American Lung Association Vaping Overview.
Regulatory Landscape and Industry Response
The FDA has authorized certain e-cigarettes as tobacco products for marketing in the United States, but the agency continues to issue warning letters and enforcement actions against unauthorized products. In 2022, the FDA's Center for Tobacco Products denied marketing applications for many flavored e-cigarettes, citing public health concerns. Companies such as Juul Labs have faced regulatory scrutiny, advertising restrictions, and legal challenges related to youth vaping trends. The FDA's enforcement actions and product standards aim to reduce the availability of high-risk vaping products that may cause lung damage. For more on FDA enforcement and tobacco product standards, see FDA Tobacco Regulatory Activities.
Public Health and Industry Accountability
Public health agencies and advocacy groups continue to push for stricter regulations on vaping product marketing, sales to minors, and ingredient disclosures. The CDC and the American Lung Association have called for comprehensive policies to address youth access and the marketing of flavored products